All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Recovery

Neuropathy

By FormBlends Medical Team · Last reviewed April 2026

Neuropathy is damage to peripheral nerves causing pain, numbness, tingling, and weakness, most commonly in the hands and feet. Diabetic neuropathy alone affects roughly 50% of people with diabetes. Nerve tissue has limited regenerative capacity, making neuroprotective and neuroregenerative compounds an active area of research for improving outcomes in these patients.

Diabetic neuropathy affects roughly 50% of people with diabetes

FormBlends Condition Context

Reviewed May 14, 2026

Treat Neuropathy condition guide as context for a safer next conversation. It should help with connect symptoms and treatment options to a safer provider conversation, while keeping the reader focused on condition-specific care, evidence limits, provider oversight, and the difference between general information and personal medical advice.

  • Confirm whether the page is discussing approved care, compounded access, off-label use, or research-only context.
  • Check the date, evidence quality, safety limits, and whether newer clinical or regulatory updates may change the answer.
  • Ask a licensed clinician how the information applies to your history, medications, labs, goals, and risk profile.

Common Symptoms

  • Tingling or pins-and-needles sensation in extremities
  • Numbness that gradually spreads from fingers or toes inward
  • Sharp, burning, or stabbing pain
  • Sensitivity to touch that is disproportionate to the stimulus
  • Muscle weakness and loss of coordination
  • Loss of balance and increased fall risk

Common Causes

  • Diabetes causing metabolic damage to nerve fibers
  • Chemotherapy-induced peripheral neuropathy
  • Chronic alcohol use damaging nerves through toxicity and nutrient depletion
  • Autoimmune conditions attacking nerve myelin or axons
  • Physical nerve compression or trauma

Treatment Options

Peptide

BPC-157

BPC-157 has shown neuroprotective properties in preclinical research, including protection against nerve crush injury and promotion of peripheral nerve regeneration through nitric oxide system modulation.

Learn more about BPC-157 →
Peptide

NAD+

NAD+ supports neuronal mitochondrial function and DNA repair mechanisms. Research suggests it may help protect nerve cells from metabolic and oxidative damage.

Learn more about NAD+ →
Lifestyle

Blood Sugar Management

For diabetic neuropathy, tight glycemic control is the most important modifiable factor. Reducing HbA1c to below 7% can slow or halt further nerve damage progression.

Find Treatment for Neuropathy

Browse clinics near you that treat neuropathy.

Find Clinics

Frequently Asked Questions

What is neuropathy?
Neuropathy is damage to peripheral nerves causing pain, numbness, tingling, and weakness, most commonly in the hands and feet. Diabetic neuropathy alone affects roughly 50% of people with diabetes. Nerve tissue has limited regenerative capacity, making neuroprotective and neuroregenerative compounds an active area of research for improving outcomes in these patients.
What are the symptoms of neuropathy?
Tingling or pins-and-needles sensation in extremities, Numbness that gradually spreads from fingers or toes inward, Sharp, burning, or stabbing pain, Sensitivity to touch that is disproportionate to the stimulus, Muscle weakness and loss of coordination, Loss of balance and increased fall risk.
What treatments are available for neuropathy?
BPC-157, NAD+, Blood Sugar Management.